Inclisiran in advanced chronic kidney disease (stage G4–G5 non-dialysis): sustained LDL-C reduction and favorable safety profile at 1-year follow-up in a real-world case series - Quiz - MDSpire

Inclisiran in advanced chronic kidney disease (stage G4–G5 non-dialysis): sustained LDL-C reduction and favorable safety profile at 1-year follow-up in a real-world case series

  • By

  • Avinash Chandu Nanwani

  • Jose Carlos De la Flor Merino

  • Elena Jiménez Mayor

  • Juan Daniel Díaz García

  • Celia Rodríguez Tudero

  • Arturo Villalobos Navarro

  • Esperanza Moral Berrio

  • Adriana Puente García

  • Jesus Hernández Vaquero

  • June 22, 2026

  • 0 min

Share

Original Source(s)

Inclisiran in advanced chronic kidney disease (stage G4–G5 non-dialysis): sustained LDL-C reduction and favorable safety profile at 1-year follow-up in a real-world case series

  • by Avinash Chandu Nanwani, Jose Carlos De la Flor Merino, Elena Jiménez Mayor, Juan Daniel Díaz García, Celia Rodríguez Tudero, Arturo Villalobos Navarro, Esperanza Moral Berrio, Adriana Puente García, Jesus Hernández Vaquero

  • June 22, 2026

Related Content

Coronary Model Shows Limits in Cath-Referred Patients

An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

The effects of combined endurance and resistance exercise training in heart failure: a meta-analysis